These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2495232)

  • 1. Steroid regulation of monoamine oxidase activity in the adrenal medulla.
    Youdim MB; Banerjee DK; Kelner K; Offutt L; Pollard HB
    FASEB J; 1989 Apr; 3(6):1753-9. PubMed ID: 2495232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B.
    Youdim MB; Banerjee DK; Pollard HB
    Science; 1984 May; 224(4649):619-21. PubMed ID: 6424235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PC12 cells as a window for the differentiation of neural crest into adrenergic nerve ending and adrenal medulla.
    Youdim MB
    J Neural Transm Suppl; 1991; 34():61-7. PubMed ID: 1817165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
    King PR; Gundlach AL; Louis WJ
    Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase in rat and bovine endocrine tissues.
    Lenzen S; Freisinger-Treichel M; Panten U
    J Neurochem; 1987 Oct; 49(4):1183-90. PubMed ID: 3305788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells.
    Yadid G; Zinder O; Youdim MB
    Br J Pharmacol; 1991 Nov; 104(3):760-4. PubMed ID: 1797336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of rat uterine monoamine oxidase activity by steroid hormones.
    Grosso DS; Gawienowski AM
    J Endocrinol; 1975 May; 65(2):207-14. PubMed ID: 1080179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T; Greube A; Strauss S; Heineke D; Lehmann J; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat.
    Borbe HO; Niebch G; Nickel B
    J Neural Transm Suppl; 1990; 32():131-7. PubMed ID: 2128496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidases A and B are differentially regulated by glucocorticoids and "aging" in human skin fibroblasts.
    Edelstein SB; Breakefield XO
    Cell Mol Neurobiol; 1986 Jun; 6(2):121-50. PubMed ID: 3731213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase in bovine thyroid tissue.
    Masini-Repiso AM; Cabanillas AM; Andrada MC; Coleoni AH
    Horm Metab Res; 1986 Nov; 18(11):750-3. PubMed ID: 3098663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the pargyline-binding site of different types of monoamine oxidase.
    Yu PH
    Can J Biochem; 1981 Jan; 59(1):30-7. PubMed ID: 6784898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.